RVL Pharmaceuticals
RVLP
#10311
Rank
โ‚ฌ2.87 M
Marketcap
0,02579ย โ‚ฌ
Share price
-32.05%
Change (1 day)
N/A
Change (1 year)

EPS for RVL Pharmaceuticals (RVLP)

EPS in 2023 (TTM): -0,66ย โ‚ฌ

According to RVL Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,64ย โ‚ฌ. In 2022 the company made an earnings per share (EPS) of -0,51ย โ‚ฌ an increase over its 2021 EPS that were of -0,87ย โ‚ฌ.

EPS history for RVL Pharmaceuticals from 2018 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-0,66ย โ‚ฌ29.16%
2022-0,51ย โ‚ฌ-41.05%
2021-0,87ย โ‚ฌ-26.36%
2020-1,18ย โ‚ฌ-75.05%
2019-4,73ย โ‚ฌ146.15%
2018-1,92ย โ‚ฌ